Insiders · Profile

BOYLE J DAVID II

CEO at Sarepta Therapeutics. Filing since 13 Mar 2009. CIK 0001331152

Company
Date
Role
Action
Shares
Amount
Of holding
27 Aug 2010
CEO
Bought
5,000
$10.65K
7.7%
13 Mar 2009
CFO
Bought
19,000
$12.14K
41.1%
2 decisions on file.